about
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.Mendelian Randomization Implicates High-Density Lipoprotein Cholesterol-Associated Mechanisms in Etiology of Age-Related Macular Degeneration.Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery disease patients.N-(3-Benzoylphenyl)-1H-Indole-2-Carboxamide decreases triglyceride levels by downregulation of Apoc3 gene expression in acute hyperlipidemic rat model.APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting ApoC-III to Reduce Coronary Disease Risk.
@en
type
label
Targeting ApoC-III to Reduce Coronary Disease Risk.
@en
prefLabel
Targeting ApoC-III to Reduce Coronary Disease Risk.
@en
P2093
P2860
P1476
Targeting ApoC-III to Reduce Coronary Disease Risk.
@en
P2093
Arman Qamar
Daniel J Rader
John S Millar
Sumeet A Khetarpal
P2860
P2888
P356
10.1007/S11883-016-0609-Y
P577
2016-09-01T00:00:00Z
P6179
1032437640